HEALTH● LOW1h ago · Oct 15, 2026, 3:22 PM
Eli Lilly's Omvoh boosted by new ulcerative colitis, Crohn's data
Seeking Alpha Tech · global
Eli Lilly's drug Omvoh has received a boost from new data regarding its efficacy against ulcerative colitis and Crohn's disease. This scientific development could impact treatment options for these conditions and the pharmaceutical market.
GlobeAlert aggregates and classifies open sources; the story above belongs to its publisher. Summaries are machine-generated from the source text.
More in Health
HEALTH32m agoCleft lip and palate and other craniofacial surgery for kids isn’t cosmetic, it’s lifesavingThe HillHEALTH46m agoHong Kong’s Hospital Authority appeals for liver donor for boy, 13South China Morning PostHEALTH59m agoInside Bunia’s fight to protect families from DRC’s deadliest Ebola outbreakRFI [en]HEALTH1h agoRoutine testosterone screening of US troops may require extensive follow-on care, study findsMilitary Times